Immutep Secures Regulatory Clearance for Phase 1 Antibody Study in Autoimmune Diseases; Shares Up 3%
Immutep Secures Regulatory Clearance for Phase 1 Antibody Study in Autoimmune Diseases; Shares Up 3%
Immutep在自身免疫性疾病Phase 1抗体研究中获得监管清关，股价上涨3%。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册